[Pulmonary thromboembolism after knee arthroscopy. Case report].
Knee arthroscopic surgery stands out as one of the most common surgical procedures in orthopedics and traumatology. The incidence of this type of procedures reaches 3.5 million procedures per year worldwide. Thromboprophylaxis is done basically with low molecular weight heparins; however, the dosing, indication and duration of therapy are currently debated. The objective is to prevent both deep venous thrombosis and pulmonary thromboembolism. The purpose is to describe a clinical case reporting the occurrence of DVP and pulmonary thromboembolism after arthroscopic knee surgery and characterize patients in detail.
J
J
Hinzpeter-Cohen
J
J
Catalán-González
A
A
Zamorano-Cadenas
D
D
Cuzmar-Grimalt
M
M
Escudero-Heldt
D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use; D001182:Arthroscopy; D058070:Asymptomatic Diseases; D017985:Dalteparin / Q000627:therapeutic use; D005260:Female; D006488:Hemostasis, Surgical / Q000009:adverse effects; D006801:Humans; D007511:Ischemia / Q000209:etiology; D007866:Leg / Q000098:blood supply; D008592:Menisci, Tibial / Q000601:surgery; D020370:Osteoarthritis, Knee / Q000000981:diagnostic imaging / Q000601:surgery*; D011183:Postoperative Complications / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000209:etiology*; D011655:Pulmonary Embolism / Q000000981:diagnostic imaging / Q000209:etiology*; D011859:Radiography; D013924:Thrombophlebitis / Q000188:drug therapy / Q000209:etiology; D013997:Time Factors
D000925:Anticoagulants; D017985:Dalteparin